… , current research is largely geared to identify and develop disease-… emerging drugs in
the management of the motor and nonmotor symptoms of PD and drugs under study as disease…

… In this Review, we discuss the emerging non-dopaminergic therapies for PD with a focus
on disease modification and treatment of motor symptoms. We examine pharmacological …

… disease modifying treatments for PD, with management options consisting mainly of dopaminergic
drugs… In this review, we discuss the emerging treatment approaches, and the form that …

… of the motor symptoms associated with Parkinson’s disease (PD). Even … drugs are being
developed to optimize the treatment response.[Citation2] Here we review new and emerging …

… It is hoped that these emerging therapies and surgical procedures will strengthen our …
This review will discuss the main emerging pharmacological therapies and non-pharmacological …

… This review focuses on drug therapy for the motor impairment in Parkinson’s disease.
Current and future research directions are summarised by taking inventory of recent and …

Introduction: Autonomic dysfunction, including orthostatic hypotension (OH), sialorrhea,
sexual dysfunction, urinary dysfunction and constipation is a common feature of Parkinson's …

Introduction: Pain affects between 40 and 85% of Parkinson's disease (PD) patients. It is a
frequently disabling and overlooked feature, which can significantly reduce health-related …

… This exemplary new book reviews some of the most outstanding examples of new drugs … to
reach the Parkinson ́s drug market in the next few years as potential disease modifying drugs. …

Parkinson’s disease (PD) is a common neurodegenerative disease typified by a movement
disorder consisting of bradykinesia, rest tremor, rigidity, and postural instability. Treatment …